I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

Clinical trial NCT01042379 · RECRUITING

Trial details

NCT number: NCT01042379
Sponsor: QuantumLeap Healthcare Collaborative
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Neoplasms Breast Cancer Breast Tumors Angiosarcoma TNBC - Triple-Negative Breast Cancer HER2-positive Breast Cancer HER2-negative Breast Cancer Hormone Receptor Positive Tumor Hormone Receptor Negative Tumor Early-stage Breast Cancer Locally Advanced Breast Cancer

Start date: 2010-03-01
Primary completion: 2030-12-01
Enrollment: 5000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.